Ricci, Enzo
 Distribuzione geografica
Continente #
EU - Europa 5.117
NA - Nord America 4.426
AS - Asia 1.832
SA - Sud America 317
AF - Africa 40
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.762
Nazione #
US - Stati Uniti d'America 4.329
DE - Germania 1.784
SE - Svezia 753
CN - Cina 724
SG - Singapore 672
IT - Italia 569
PL - Polonia 435
UA - Ucraina 431
BR - Brasile 290
IE - Irlanda 231
GB - Regno Unito 216
FR - Francia 206
FI - Finlandia 201
ID - Indonesia 148
RU - Federazione Russa 90
IN - India 89
CA - Canada 61
TR - Turchia 55
NL - Olanda 40
HK - Hong Kong 33
BE - Belgio 32
ES - Italia 29
JP - Giappone 24
AT - Austria 22
AU - Australia 22
CI - Costa d'Avorio 20
MX - Messico 20
KR - Corea 19
IR - Iran 16
CH - Svizzera 15
AR - Argentina 10
CZ - Repubblica Ceca 10
MA - Marocco 8
VN - Vietnam 8
BD - Bangladesh 7
RO - Romania 7
UZ - Uzbekistan 7
SK - Slovacchia (Repubblica Slovacca) 6
BG - Bulgaria 5
CL - Cile 5
EC - Ecuador 5
LV - Lettonia 5
PA - Panama 5
PT - Portogallo 5
ZA - Sudafrica 5
GR - Grecia 4
LT - Lituania 4
AM - Armenia 3
BZ - Belize 3
DK - Danimarca 3
EG - Egitto 3
HU - Ungheria 3
LU - Lussemburgo 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PE - Perù 3
PR - Porto Rico 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
MN - Mongolia 2
PH - Filippine 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
GE - Georgia 1
GY - Guiana 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MY - Malesia 1
PK - Pakistan 1
PY - Paraguay 1
QA - Qatar 1
TM - Turkmenistan 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 11.762
Città #
Chandler 779
Warsaw 422
Singapore 401
Ashburn 396
Jacksonville 253
San Mateo 237
Munich 228
Dublin 224
Nanjing 153
Wilmington 147
Jakarta 146
Ann Arbor 145
Woodbridge 122
Houston 114
Nürnberg 114
Fairfield 111
New York 104
Boston 99
Helsinki 99
Rome 97
Dearborn 94
Milan 88
Moscow 70
Lawrence 67
Seattle 67
Princeton 63
Redwood City 63
Nanchang 61
Cattolica 59
Beijing 48
Bremen 46
Izmir 43
Chicago 42
Los Angeles 38
Chengdu 37
Marseille 37
Cambridge 34
Ottawa 34
Shenyang 34
Hebei 31
Redmond 29
Hangzhou 27
Mountain View 27
University Park 27
Jiaxing 26
Kunming 26
Boardman 25
San Jose 25
Changsha 23
Leawood 23
Norwalk 22
São Paulo 22
Detroit 21
Hong Kong 21
Nuremberg 21
Abidjan 20
Lancaster 20
Shanghai 20
Washington 20
Brussels 19
Düsseldorf 19
Sydney 18
Madrid 17
Seoul 17
The Dalles 17
Tianjin 17
Fremont 16
Saint Louis 15
Toronto 15
Zhengzhou 15
Frankfurt am Main 14
Belo Horizonte 13
Guangzhou 13
Inverigo 13
North Bergen 13
Las Vegas 12
Rio de Janeiro 12
Vienna 12
London 11
Berlin 10
Palermo 10
Pune 10
Jyväskylä 9
Kraków 9
Paris 9
Augusta 8
Bologna 8
Kish 8
Lanzhou 8
Ningbo 8
Philadelphia 8
Phoenix 8
Andover 7
Antwerp 7
Busto Arsizio 7
Curitiba 7
Florence 7
Lauterbourg 7
Oristano 7
Auburn Hills 6
Totale 6.358
Nome #
Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients 335
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. 326
An immunological analysis of dystroglycan subunits: lessons learned from a small cohort of non-congenital dystrophic patients. 292
Balance and walking in facioscapulohumeral muscular dystrophy: multiperspective assessment 213
A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia 203
Sleeep quality in Facioscapulohumeral muscular dystrophy. 202
Upper body involvement in GNE myopathy assessed by muscle imaging 201
Alternative splicing alterations of Ca(2+) handling genes are associated with Ca(2+) signal dysregulation in DM1 and DM2 myotubes 197
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 169
Hospital admissions from the emergency department of adult patients affected by myopathies 163
Cephalometric findings in facioscapulohumeral muscular dystrophy patients with obstructive sleep apneas 156
Balance and walking involvement in Facioscapulohumeral Muscular Dystrophy (FSHD): a pilot study on the effects of custom lower limb orthoses 154
Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging 153
Decreased nocturnal movements in patients with facioscapulohumeral muscular dystrophy 149
alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy 148
Heart rate variability in facioscapulohumeral muscular dystrophy. 147
Analysis of ryanodine receptor 1 (RyR1) and voltage-gated Ca2+ channel (VGCC) alpha1S subunit (Cav1.1) pre-mRNA splicing and correlation with intracellular calcium signals in myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2) myotubes. 145
Pain and the Alpha-Sleep Anomaly: A Mechanism of Sleep Disruption in Facioscapulohumeral Muscular Dystrophy 145
Chronic GM2 gangliosidosis type Sandhoff associated with a novel missense HEXB gene mutaton causing a double patogenetic effect 140
Muscle imaging findings in GNE myopathy 136
Sleep quality in Facioscapulohumeral muscular dystrophy 135
Quality of Life and Pain assessment in patients with facioscapulohumeral muscular dystrophy 133
Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes. 124
Monoclonal antibody fragment from combinatorial phage display library neutralizes alpha-latrotoxin activity and abolishes black widow spider venom lethality, in mice 122
Muscle MRI in Becker muscular dystrophy 122
Myotonic dystrophy type 1 and de novo FSHD mutation double trouble: A clinical and muscle MRI study 122
Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior. 119
Mitochondrial network genes in the skeletal muscle of amyotrophic lateral sclerosis patients. 117
Muscle MRI in female carriers of dystrophinopathy 113
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study 112
Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort 111
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 111
Muscle MRI in Becker muscular dystrophy 108
Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle 105
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 105
Congenital muscular dystrophies with cognitive impairment. A population study 104
Truncation of Caveolin-3 causes autosomal-recessive Rippling Muscle Disease 102
Upper Girdle Imaging in Facioscapulohumeral Muscular Dystrophy 102
Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients 101
Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles 101
Magnetic Resonance Imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: pattern refinement and implications for clinical trials 96
Coeliac disease presenting with acute disseminated encephalomyelitis 95
Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy 94
Limb-girdle muscular dystrophy with α-dystroglycan deficiency and mutations in the ISPD gene 93
New phenotype and pathology features in MYH7-related distal myopathy 92
Sleep disordered breathing in facioscapulohumeral muscular dystrophy. 91
Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis. 90
Estrogens enhance myoblast differentiation in facioscapulohumeral muscular dystrophy by antagonizing DUX4 activity 89
Allele-specific DNA hypomethylation characterises FSHD1 and FSHD2 88
Ocular palsies in the absence of other neurological or ocular symptoms: analysis of 105 cases 86
Calf muscle involvement in Becker muscular dystrophy: When size does not matter 86
Remitting-Relapsing Carbamazepine Overdosage Mimicking Vertebrobasilar Transient Ischemic Attacks 83
Diagnostic magnetic resonance imaging biomarkers for facioscapulohumeral muscular dystrophy identified by machine learning 83
Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma. 82
An Italian case of hereditary myopathy with early respiratory failure (HMERF) not associated with the titin kinase domain R279W mutation 81
Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2). 81
Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy 81
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study 81
Coeliac disease presenting with acute disseminated encephalomyelitis. 79
MRI neurography findings in patients with idiopathic brachial plexopathy: correlations with clinical-neurophysiological data in eight consecutive cases 79
Teaching video neuroimages: complicated scapular winging 78
Severe 5,10-methylenetetrahydrofolate reductase deficiency: A rare, treatable cause of complicated hereditary spastic paraplegia 75
Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging 75
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene 74
Increased aging in primary muscle cultures of sporadic inclusion-body myositis. 74
MRI in sarcoglycanopathies: a large international cohort study 73
Proteomics of muscle microdialysates identifies potential circulating biomarkers in facioscapulohumeral muscular dystrophy 72
Prevalence of congenital muscular dystrophy in Italy: a population study 71
Magnetic resonance imaging pattern recognition in sporadic Inclusion-Body Myositis 69
Upper girdle imaging in facioscapulohumeral muscular dystrophy 67
Muscle hypertrophy in amyloid myopathy 67
Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis 66
To the Editor: Fasciculations in Late-Onset Pompe Disease: A Sign of Motor Neuron Involvement? 66
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 66
MRI neurography findings in patients with idiopathic brachial plexopathy: correlations with clinical-neurophysiological data in eight consecutive cases 65
Mixed connective tissue disease presenting as a peculiar myositis with poor muscle regeneration 65
An Exceptional Case of Acute Respiratory Failure Caused by Intra-Thoracic Gastric Perforation Secondary to Overeating 65
Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study 63
Surgical Decision-Making in Spinal Instability in Facioscapulohumeral Muscular Dystrophy Related with a Spinal Muscle Atrophy 63
Dynamic magnetic resonance imaging of muscle contraction in facioscapulohumeral muscular dystrophy 63
Mouth leaks may complicate positive airway pressure treatment of OSAS in facioscapulohumeral muscular dystrophy. 62
'Pathognomonic' muscle imaging findings in DNAJB6 mutated LGMD1D 60
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 59
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. 59
Music exposure differentially alters the levels of brain-derived neurotrophic factor and nerve growth factor in the mouse hypothalamus. 58
Somatic mosaicism in TPM2-related myopathy with nemaline rods and cap structures. 58
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 58
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 58
A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score. 57
European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A) 57
Technology outcome measures in neuromuscular disorders: A systematic review 56
The genetic basis of undiagnosed muscular dystrophies and myopathies 55
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 55
Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy 55
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials 54
Muscle Microdialysis to Investigate Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy 53
Investigating the neurobiology of music: brain-derived neurotrophic factor modulation in the hippocampus of young adult mice. 52
Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy 52
Concentric muscle involvement in POLG-related distal myopathy 52
COVID-19 pandemic and days of absence from work in workers with flu-like symptoms in the City of Rome, Italy 52
Totale 10.272
Categoria #
all - tutte 53.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.050


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020253 0 0 0 0 0 0 0 0 0 0 142 111
2020/20211.109 36 113 26 118 146 45 139 22 161 54 211 38
2021/20221.235 92 94 30 87 49 70 22 194 88 61 213 235
2022/20232.272 283 289 193 330 178 298 76 177 302 29 57 60
2023/20241.317 50 340 40 81 37 167 115 72 20 54 174 167
2024/20252.052 67 87 233 62 207 138 177 206 441 228 206 0
Totale 11.935